Owing to its critical role, studies have observed overexpressed ANLN in several types of cancers [24–26], and it has also been proven to be correlated with poor prognoses in breast cancer, lung cancer and hepatocellular carcinoma [27–29]. The gene discussed is ANLN; the disease is hepatocellular carcinoma.